Clinical Trial Update: MagDI Australia Study [NA]

View source ↗

Summary

This update notes that the MagDI Australia Study, sponsored by GT Metabolic Solutions, Inc., is currently active but not recruiting and targets obesity and type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• MagDI

Snippet

Sponsor: GT Metabolic Solutions, Inc. | Conditions: Obesity, Type 2 Diabetes | NA | Status: ACTIVE_NOT_RECRUITING